Back to Journals » Drug Design, Development and Therapy » Volume 16

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights

Total article views   HTML views PDF downloads Totals
5,878 Dovepress* 5,732+ 359 6,091
PubMed Central* 146 87 233
Totals 5,878 446 6,324
*Since 16 May 2022

View citations on PubMed Central and Google Scholar